Loading...
Author Verified
RCT
Published: Oct 2011
ACE Report #4589
Ace Report Cover Metabolic Disorders

Eldecalcitol reduces risk of vertebral fractures in osteoporotic patients


Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study

Bone. 2011 Oct;49(4):605-12. doi: 10.1016/j.bone.2011.07.011. Epub 2011 Jul 19

Contributing Authors: T Nakamura T Matsumoto M Ito Y Hayashi T Hirota Y Tanigawara T Sone M Fukunaga M Shiraki

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.